RISPERIDONE

RISPERIDONE was reported 75396 times

RISPERIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GYNAECOMASTIA 24656 0.7962
1 ABNORMAL WEIGHT GAIN 9459 0.7650
2 HYPERPROLACTINAEMIA 4514 0.6956
3 BLOOD PROLACTIN ABNORMAL 545 0.6315
4 GALACTORRHOEA 3786 0.5888
5 ANOSOGNOSIA 447 0.5820
6 EXPOSURE TO CONTAMINATED DEVICE 132 0.5019
7 TOTAL LUNG CAPACITY INCREASED 98 0.3603
8 BLOOD PROLACTIN INCREASED 1559 0.3303
9 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 210 0.3039
10 PLEUROTHOTONUS 227 0.2511
11 MALIGNANT CATATONIA 63 0.2395
12 DELUSION OF GRANDEUR 106 0.2361
13 OBESITY 3722 0.2334
14 COGWHEEL RIGIDITY 245 0.2333
15 DISTURBANCE IN SOCIAL BEHAVIOUR 547 0.2320
16 DELUSIONAL DISORDER, PERSECUTORY TYPE 92 0.2196
17 SPASMODIC DYSPHONIA 65 0.2145
18 SCHIZOPHRENIA, PARANOID TYPE 75 0.2083
19 OCULOGYRIC CRISIS 445 0.2072
20 OROMANDIBULAR DYSTONIA 143 0.1962
21 EMOTIONAL DISORDER 5963 0.1932
22 NEUROLEPTIC MALIGNANT SYNDROME 2265 0.1908
23 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 98 0.1874
24 SELF INJURIOUS BEHAVIOUR 549 0.1798
25 SCHIZOPHRENIA 2166 0.1781
26 PSYCHIATRIC DECOMPENSATION 330 0.1687
27 SCHIZOAFFECTIVE DISORDER 296 0.1658
28 CATATONIA 843 0.1604
29 WRONG PATIENT 79 0.1574
30 GRANDIOSITY 56 0.1530
31 PSYCHOTIC SYMPTOM 316 0.1530
32 ANTICHOLINERGIC SYNDROME 229 0.1437
33 BREAST ENLARGEMENT 466 0.1421
34 EXTRAPYRAMIDAL DISORDER 3489 0.1404
35 DISINHIBITION 226 0.1403
36 METABOLIC SYNDROME 224 0.1363
37 WATER INTOXICATION 65 0.1285
38 SOLILOQUY 111 0.1283
39 METABOLIC DISORDER 741 0.1275
40 BREAST DISCHARGE 218 0.1243
41 AKATHISIA 1672 0.1224
42 BLUNTED AFFECT 88 0.1192
43 PROTRUSION TONGUE 69 0.1184
44 PARKINSONISM 1155 0.1183
45 DEVICE USE CONFUSION 60 0.1147
46 PARKINSONIAN GAIT 71 0.1138
47 PERSECUTORY DELUSION 284 0.1138
48 OVERWEIGHT 583 0.1084
49 HALLUCINATION, AUDITORY 1718 0.1080
50 PSYCHOMOTOR SKILLS IMPAIRED 283 0.1079
51 PRIAPISM 372 0.1078
52 SEDATION COMPLICATION 275 0.1077
53 SELF-DESTRUCTIVE BEHAVIOUR 91 0.1044
54 EMOTIONAL POVERTY 181 0.1032
55 MUTISM 146 0.1005
56 PITUITARY TUMOUR BENIGN 161 0.0987
57 SEDATION 2529 0.0965
58 PSYCHOTIC DISORDER 2802 0.0948
59 PSYCHOMOTOR RETARDATION 266 0.0946
60 DIABETIC COMA 265 0.0945
61 DYSTONIA 1758 0.0905
62 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 80 0.0899
63 SALIVARY HYPERSECRETION 874 0.0873
64 HYPERAMMONAEMIC ENCEPHALOPATHY 149 0.0856
65 HYPOMANIA 314 0.0853
66 WRONG PATIENT RECEIVED PRODUCT 246 0.0840
67 TORTICOLLIS 175 0.0825
68 STEREOTYPY 74 0.0785
69 INAPPROPRIATE AFFECT 123 0.0776
70 OPISTHOTONUS 60 0.0755
71 SEXUAL DYSFUNCTION 882 0.0751
72 DELUSION 1160 0.0746
73 DIABETES MELLITUS NON-INSULIN-DEPENDENT 107 0.0735
74 MUSCLE RIGIDITY 863 0.0721
75 TIC 385 0.0705
76 DIABETIC NEUROPATHY 346 0.0698
77 DEPRESSIVE SYMPTOM 246 0.0697
78 GAZE PALSY 118 0.0692
79 MULTIPLE DRUG OVERDOSE INTENTIONAL 220 0.0683
80 STUPOR 218 0.0678
81 OBSESSIVE-COMPULSIVE DISORDER 544 0.0677
82 ANTIPSYCHOTIC DRUG LEVEL INCREASED 190 0.0674
83 PSYCHOTIC BEHAVIOUR 68 0.0669
84 DROOLING 457 0.0661
85 INJURY 4643 0.0660
86 HYPOTHERMIA 658 0.0649
87 BREAST DISORDER 130 0.0637
88 INTELLECTUAL DISABILITY 96 0.0632
89 STARING 152 0.0628
90 TARDIVE DYSKINESIA 1760 0.0623
91 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 138 0.0617
92 PARANOIA 1059 0.0614
93 POLYDIPSIA 241 0.0609
94 HOMICIDAL IDEATION 246 0.0606
95 INFERTILITY 90 0.0598
96 TYPE 1 DIABETES MELLITUS 356 0.0590
97 JAUNDICE CHOLESTATIC 205 0.0580
98 INTRUSIVE THOUGHTS 68 0.0577
99 GLYCOSURIA 77 0.0570
100 ACUTE PSYCHOSIS 139 0.0561
101 AGGRESSION 2812 0.0561
102 PERSONALITY CHANGE 521 0.0560
103 TYPE 2 DIABETES MELLITUS 1859 0.0552
104 BIPOLAR I DISORDER 121 0.0551
105 INCREASED APPETITE 1051 0.0549
106 HYPERPHAGIA 216 0.0541
107 DEMENTIA WITH LEWY BODIES 59 0.0530
108 INTENTIONAL SELF-INJURY 1063 0.0526
109 HALLUCINATIONS, MIXED 221 0.0525
110 ENURESIS 212 0.0524
111 HYPERSEXUALITY 95 0.0519
112 SUICIDE ATTEMPT 3141 0.0518
113 IMPAIRED SELF-CARE 107 0.0516
114 DYSLIPIDAEMIA 262 0.0515
115 FLAT AFFECT 118 0.0509
116 TREATMENT NONCOMPLIANCE 2778 0.0507
117 SYSTEMIC INFECTION 84 0.0506
118 LYMPHOCYTE COUNT ABNORMAL 57 0.0506
119 SOCIAL AVOIDANT BEHAVIOUR 293 0.0506
120 MANIA 829 0.0503
121 DYSKINESIA 2046 0.0503
122 LOGORRHOEA 176 0.0499
123 DIABETIC COMPLICATION 125 0.0490
124 DEPRESSION SUICIDAL 169 0.0488
125 TEARFULNESS 208 0.0483
126 BEHAVIOUR DISORDER 257 0.0475
127 BODY MASS INDEX INCREASED 64 0.0474
128 ILLUSION 77 0.0465
129 OBSESSIVE THOUGHTS 83 0.0460
130 ALCOHOL ABUSE 122 0.0456
131 COMMUNICATION DISORDER 172 0.0449
132 CONDUCTION DISORDER 82 0.0447
133 SOPOR 586 0.0442
134 SINUS ARRHYTHMIA 57 0.0437
135 PERSONALITY DISORDER 112 0.0427
136 EXCESSIVE EYE BLINKING 63 0.0426
137 FEELING GUILTY 56 0.0424
138 HOSTILITY 107 0.0421
139 WEIGHT INCREASED 9289 0.0414
140 IMPULSIVE BEHAVIOUR 155 0.0413
141 ABNORMAL BEHAVIOUR 1631 0.0411
142 HYPERTHERMIA 314 0.0411
143 AUTONOMIC NERVOUS SYSTEM IMBALANCE 118 0.0404
144 HYPERTONIA 231 0.0403
145 EMBOLISM VENOUS 122 0.0402
146 AKINESIA 83 0.0400
147 PSYCHIATRIC SYMPTOM 290 0.0393
148 ELECTROENCEPHALOGRAM ABNORMAL 124 0.0392
149 PHYSICAL ASSAULT 82 0.0392
150 IMPRISONMENT 69 0.0390
151 POSTURE ABNORMAL 125 0.0384
152 LANGUAGE DISORDER 83 0.0384
153 PARADOXICAL DRUG REACTION 140 0.0380
154 AFFECTIVE DISORDER 298 0.0379
155 THERAPEUTIC PRODUCT EFFECT VARIABLE 147 0.0378
156 BRADYKINESIA 223 0.0377
157 HYPERLIPIDAEMIA 451 0.0377
158 DIABETES MELLITUS 2837 0.0372
159 FOREIGN BODY 148 0.0369
160 SEROTONIN SYNDROME 703 0.0366
161 GLUCOSE TOLERANCE IMPAIRED 216 0.0365
162 REFUSAL OF TREATMENT BY PATIENT 237 0.0363
163 SYRINGE ISSUE 632 0.0361
164 MYOCARDITIS 409 0.0356
165 PSYCHOMOTOR HYPERACTIVITY 585 0.0352
166 BIPOLAR DISORDER 382 0.0351
167 DELIRIUM 1219 0.0351
168 ACCIDENTAL DEATH 65 0.0349
169 EOSINOPHIL COUNT DECREASED 83 0.0348
170 CHOREA 60 0.0348
171 SELF-INJURIOUS IDEATION 146 0.0348
172 LONG QT SYNDROME 83 0.0346
173 GRANULOCYTOPENIA 197 0.0345
174 ILEUS PARALYTIC 153 0.0342
175 INSULIN RESISTANCE 71 0.0341
176 MAJOR DEPRESSION 249 0.0340
177 SINUS TACHYCARDIA 482 0.0339
178 GAMBLING DISORDER 91 0.0337
179 BLOOD TRIGLYCERIDES INCREASED 594 0.0336
180 AGITATION 2467 0.0336
181 PNEUMONIA ASPIRATION 836 0.0334
182 RESTLESSNESS 1223 0.0334
183 ELECTROCARDIOGRAM QT PROLONGED 1199 0.0333
184 HYPERGLYCAEMIA 1214 0.0333
185 BLOOD CREATINE PHOSPHOKINASE INCREASED 954 0.0331
186 HYPERKINESIA 70 0.0330
187 CEREBRAL ATROPHY 131 0.0328
188 EYE MOVEMENT DISORDER 222 0.0324
189 GESTATIONAL DIABETES 154 0.0323
190 AMENORRHOEA 563 0.0321
191 MIOSIS 256 0.0319
192 SLUGGISHNESS 323 0.0316
193 HYPERREFLEXIA 110 0.0315
194 SUDDEN DEATH 327 0.0309
195 HALLUCINATION, VISUAL 645 0.0305
196 WRONG PRODUCT ADMINISTERED 205 0.0303
197 RHINITIS ALLERGIC 135 0.0303
198 APATHY 440 0.0301
199 DEPRESSED LEVEL OF CONSCIOUSNESS 1192 0.0301
200 HYPERLACTACIDAEMIA 80 0.0298
201 ALTERED STATE OF CONSCIOUSNESS 638 0.0294
202 SUICIDAL IDEATION 2692 0.0294
203 EMOTIONAL DISTRESS 3540 0.0292
204 INTENTIONAL OVERDOSE 1871 0.0291
205 SUICIDAL BEHAVIOUR 121 0.0291
206 DIABETES INSIPIDUS 70 0.0290
207 INCOHERENT 188 0.0290
208 DRUG INTERACTION 4599 0.0290
209 SCREAMING 184 0.0289
210 FAECALOMA 158 0.0288
211 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 296 0.0288
212 MULTIPLE DRUG OVERDOSE 143 0.0288
213 IMPULSE-CONTROL DISORDER 58 0.0282
214 HYPERAMMONAEMIA 140 0.0280
215 EUPHORIC MOOD 285 0.0278
216 THINKING ABNORMAL 518 0.0278
217 RHABDOMYOLYSIS 1152 0.0276
218 EJACULATION DISORDER 78 0.0275
219 DEREALISATION 59 0.0274
220 MENTAL IMPAIRMENT 651 0.0268
221 DIABETIC NEPHROPATHY 59 0.0268
222 BRADYPHRENIA 175 0.0268
223 HYPERNATRAEMIA 133 0.0267
224 TACHYPHRENIA 92 0.0265
225 POTENTIATING DRUG INTERACTION 89 0.0265
226 POISONING DELIBERATE 249 0.0262
227 BUNDLE BRANCH BLOCK RIGHT 120 0.0261
228 BLOOD CHLORIDE DECREASED 67 0.0260
229 URINARY INCONTINENCE 769 0.0259
230 SLOW SPEECH 63 0.0259
231 ATAXIA 306 0.0258
232 DIABETES MELLITUS INADEQUATE CONTROL 454 0.0256
233 ORTHOSTATIC HYPOTENSION 444 0.0255
234 INCONTINENCE 267 0.0252
235 COMA 1191 0.0250
236 BRAIN INJURY 249 0.0248
237 HYPERTRIGLYCERIDAEMIA 145 0.0247
238 SINUS BRADYCARDIA 238 0.0246
239 PRODUCT USE IN UNAPPROVED INDICATION 6038 0.0243
240 RESPIRATORY DEPRESSION 298 0.0243
241 ELECTROCARDIOGRAM ABNORMAL 189 0.0241
242 MYOCLONUS 287 0.0240
243 DEVICE LEAKAGE 1042 0.0240
244 HYPOTONIA 238 0.0238
245 AUTISM SPECTRUM DISORDER 130 0.0236
246 PARKINSON'S DISEASE 60 0.0236
247 SARCOIDOSIS 112 0.0236
248 ACCIDENTAL EXPOSURE 98 0.0235
249 TRISMUS 121 0.0234
250 BRUXISM 126 0.0233
251 BREAST SWELLING 62 0.0230
252 DYSARTHRIA 865 0.0230
253 COMPARTMENT SYNDROME 59 0.0226
254 DIABETIC KETOACIDOSIS 537 0.0223
255 SOMNOLENCE 4490 0.0223
256 DYSPHEMIA 97 0.0221
257 ERECTILE DYSFUNCTION 564 0.0219
258 TORSADE DE POINTES 172 0.0219
259 BLOOD SODIUM INCREASED 59 0.0219
260 RHINALGIA 60 0.0218
261 NEUTROPHIL COUNT INCREASED 222 0.0217
262 HALLUCINATION 1592 0.0211
263 THERAPEUTIC AGENT TOXICITY 70 0.0210
264 AREFLEXIA 56 0.0210
265 COMPLETED SUICIDE 1747 0.0209
266 NASAL POLYPS 103 0.0209
267 CARDIAC MURMUR 178 0.0206
268 DIABETIC RETINOPATHY 69 0.0203
269 TACHYCARDIA 1791 0.0201
270 DYSPHORIA 102 0.0201
271 URINARY RETENTION 669 0.0200
272 POLYURIA 164 0.0200
273 GRAND MAL CONVULSION 183 0.0198
274 MENTAL DISORDER 853 0.0196
275 FAECAL INCONTINENCE 94 0.0195
276 BLOOD CHOLESTEROL INCREASED 903 0.0194
277 HYPONATRAEMIA 1091 0.0193
278 POISONING 242 0.0192
279 HIGH DENSITY LIPOPROTEIN DECREASED 64 0.0192
280 HYPERCHOLESTEROLAEMIA 184 0.0190
281 HYPERSOMNIA 546 0.0190
282 POST-TRAUMATIC STRESS DISORDER 126 0.0188
283 LEUKOPENIA 940 0.0188
284 ATRIOVENTRICULAR BLOCK SECOND DEGREE 57 0.0188
285 TENSION 114 0.0187
286 METABOLIC ENCEPHALOPATHY 56 0.0186
287 COGNITIVE DISORDER 871 0.0186
288 MOTOR DYSFUNCTION 190 0.0186
289 HAEMODYNAMIC INSTABILITY 142 0.0186
290 MASTICATION DISORDER 57 0.0186
291 DISTURBANCE IN ATTENTION 1004 0.0186
292 MUSCLE TWITCHING 429 0.0186
293 PANIC DISORDER 72 0.0186
294 PRESCRIBED OVERDOSE 358 0.0185
295 CONGESTIVE CARDIOMYOPATHY 77 0.0185
296 ANGER 618 0.0183
297 ADVERSE EVENT 1673 0.0181
298 IRRITABILITY 1088 0.0181
299 IMMOBILE 79 0.0181
300 CYTOLYTIC HEPATITIS 60 0.0181
301 DRUG LEVEL INCREASED 299 0.0180
302 SUBSTANCE ABUSE 145 0.0178
303 ATRIOVENTRICULAR BLOCK FIRST DEGREE 77 0.0177
304 MENTAL STATUS CHANGES 491 0.0177
305 LEUKOCYTOSIS 319 0.0176
306 AFFECT LABILITY 169 0.0175
307 EATING DISORDER 373 0.0175
308 EPILEPSY 535 0.0175
309 MUSCLE CONTRACTIONS INVOLUNTARY 61 0.0173
310 LISTLESS 57 0.0173
311 BUNDLE BRANCH BLOCK LEFT 73 0.0172
312 TACHYPNOEA 233 0.0171
313 SPEECH DISORDER 897 0.0171
314 STATUS EPILEPTICUS 193 0.0171
315 BREAST MASS 114 0.0170
316 ASPHYXIA 138 0.0169
317 ALCOHOLISM 72 0.0168
318 GENERALISED TONIC-CLONIC SEIZURE 278 0.0168
319 DISORIENTATION 664 0.0167
320 BREAST PAIN 177 0.0166
321 MYDRIASIS 211 0.0164
322 DEMENTIA 459 0.0164
323 HEPATOCELLULAR INJURY 231 0.0163
324 DECREASED INTEREST 95 0.0161
325 ASPIRATION 176 0.0161
326 HYPOKINESIA 233 0.0160
327 BLOOD CHOLESTEROL ABNORMAL 74 0.0160
328 LOSS OF LIBIDO 144 0.0160
329 MEDICATION ERROR 885 0.0159
330 TOXICITY TO VARIOUS AGENTS 2681 0.0159
331 BRONCHIECTASIS 107 0.0159
332 DRUG TOXICITY 216 0.0158
333 TONGUE DISORDER 114 0.0157
334 NEEDLE ISSUE 457 0.0157
335 TREMOR 2598 0.0156
336 INTRACRANIAL PRESSURE INCREASED 87 0.0156
337 VENTRICULAR ARRHYTHMIA 57 0.0156
338 HORMONE LEVEL ABNORMAL 76 0.0156
339 COLITIS ISCHAEMIC 105 0.0155
340 CONFUSIONAL STATE 2498 0.0154
341 HEPATIC CYTOLYSIS 197 0.0154
342 LEFT VENTRICULAR HYPERTROPHY 66 0.0154
343 SNORING 58 0.0153
344 UNRESPONSIVE TO STIMULI 392 0.0152
345 PANCREATITIS 800 0.0151
346 NYSTAGMUS 80 0.0151
347 KETOACIDOSIS 112 0.0150
348 PRODUCT USE ISSUE 2812 0.0149
349 PEMPHIGOID 112 0.0148
350 TOXIC ENCEPHALOPATHY 75 0.0148
351 FEELING OF DESPAIR 69 0.0148
352 DEVICE OCCLUSION 207 0.0147
353 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 130 0.0147
354 WITHDRAWAL SYNDROME 617 0.0147
355 BRADYCARDIA 776 0.0146
356 LEFT VENTRICULAR DYSFUNCTION 98 0.0146
357 THERMAL BURN 103 0.0145
358 PETIT MAL EPILEPSY 74 0.0145
359 MENSTRUAL DISORDER 120 0.0145
360 PROCEDURAL COMPLICATION 111 0.0145
361 OFF LABEL USE 12590 0.0144
362 AGRANULOCYTOSIS 267 0.0144
363 INJECTION SITE NODULE 158 0.0143
364 SELF-MEDICATION 59 0.0143
365 APHASIA 429 0.0142
366 HEPATIC STEATOSIS 264 0.0142
367 CONVULSION 808 0.0141
368 BLEPHAROSPASM 88 0.0140
369 DRUG ABUSE 1163 0.0140
370 NEUROLOGICAL SYMPTOM 79 0.0138
371 LETHARGY 793 0.0138
372 SOCIAL PROBLEM 57 0.0138
373 CHOLELITHIASIS 451 0.0137
374 CARDIO-RESPIRATORY ARREST 567 0.0135
375 ELECTROLYTE IMBALANCE 157 0.0135
376 RESTLESS LEGS SYNDROME 245 0.0135
377 DEVICE MALFUNCTION 946 0.0134
378 NEUTROPHILIA 76 0.0133
379 BEDRIDDEN 174 0.0132
380 SLEEP APNOEA SYNDROME 252 0.0132
381 DECUBITUS ULCER 106 0.0130
382 VENTRICULAR EXTRASYSTOLES 135 0.0130
383 DRUG ADMINISTRATION ERROR 394 0.0128
384 FLANK PAIN 120 0.0128
385 HEPATOTOXICITY 285 0.0128
386 DRUG DOSE OMISSION 2112 0.0128
387 BLOOD SODIUM DECREASED 239 0.0127
388 METABOLIC ACIDOSIS 403 0.0126
389 BRAIN OEDEMA 158 0.0125
390 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 64 0.0125
391 DYSPHAGIA 1185 0.0125
392 ENCEPHALOPATHY 306 0.0124
393 MOVEMENT DISORDER 400 0.0124
394 SUPRAVENTRICULAR TACHYCARDIA 119 0.0124
395 DRUG LEVEL DECREASED 126 0.0124
396 HYPOGLYCAEMIA 600 0.0124
397 COORDINATION ABNORMAL 171 0.0122
398 PANCREATITIS ACUTE 275 0.0122
399 CIRCULATORY COLLAPSE 208 0.0122
400 FLUID INTAKE REDUCED 61 0.0122
401 SHOCK 280 0.0122
402 HUNGER 169 0.0121
403 BREAST TENDERNESS 91 0.0121
404 HYPERVENTILATION 70 0.0121
405 SEIZURE 1390 0.0120
406 WRONG DRUG ADMINISTERED 107 0.0120
407 HAEMATOCRIT DECREASED 238 0.0120
408 APNOEA 93 0.0119
409 DEPRESSION 2701 0.0119
410 MOOD SWINGS 377 0.0118
411 FEAR 317 0.0118
412 PRODUCT CONTAINER ISSUE 100 0.0117
413 LIVER FUNCTION TEST ABNORMAL 339 0.0116
414 ANXIETY 3304 0.0116
415 TROPONIN INCREASED 88 0.0116
416 DRUG ABUSER 71 0.0115
417 CACHEXIA 59 0.0115
418 GAMMA-GLUTAMYLTRANSFERASE INCREASED 254 0.0114
419 FOOD CRAVING 60 0.0114
420 PRODUCT ADMINISTRATION ERROR 230 0.0114
421 ACCIDENTAL OVERDOSE 416 0.0114
422 OLIGURIA 70 0.0113
423 RALES 65 0.0112
424 VISUAL DISTURBANCE 64 0.0111
425 DRUG PRESCRIBING ERROR 213 0.0111
426 HOSPITALISATION 1694 0.0110
427 BLOOD LACTIC ACID INCREASED 58 0.0110
428 REBOUND EFFECT 124 0.0110
429 MOOD ALTERED 297 0.0109
430 PRODUCT LEAKAGE 61 0.0109
431 DRUG USE DISORDER 91 0.0108
432 ADVERSE DRUG REACTION 972 0.0108
433 WHITE BLOOD CELL COUNT INCREASED 413 0.0108
434 C-REACTIVE PROTEIN INCREASED 391 0.0107
435 DEPRESSED MOOD 567 0.0107
436 APPETITE DISORDER 71 0.0107
437 TRICUSPID VALVE INCOMPETENCE 85 0.0107
438 HYPOTENSION 2126 0.0106
439 HYPOVOLAEMIA 62 0.0106
440 CONDITION AGGRAVATED 3219 0.0106
441 NIGHTMARE 366 0.0106
442 INSOMNIA 2812 0.0105
443 ANHEDONIA 277 0.0105
444 BLOOD BILIRUBIN INCREASED 284 0.0105
445 CHOKING 205 0.0105
446 OVERDOSE 2261 0.0105
447 DECREASED ACTIVITY 113 0.0105
448 MUSCULOSKELETAL STIFFNESS 915 0.0104
449 THERAPY CESSATION 535 0.0104
450 HEPATIC ENCEPHALOPATHY 97 0.0104
451 HYPOKALAEMIA 477 0.0103
452 INITIAL INSOMNIA 106 0.0103
453 GENERAL PHYSICAL CONDITION ABNORMAL 70 0.0103
454 CYANOSIS 162 0.0103
455 DRUG RESISTANCE 263 0.0102
456 BLOOD TESTOSTERONE DECREASED 70 0.0102
457 CARDIOMYOPATHY 151 0.0102
458 CHOLESTASIS 196 0.0102
459 LEUKAEMIA 96 0.0102
460 PULMONARY EMBOLISM 964 0.0101
461 ILEUS 126 0.0101
462 ANURIA 87 0.0101
463 MALNUTRITION 113 0.0101
464 RESPIRATORY ARREST 278 0.0101
465 RESPIRATORY DISTRESS 278 0.0101
466 THERAPY PARTIAL RESPONDER 157 0.0101
467 RENAL FAILURE CHRONIC 77 0.0100
468 PANIC REACTION 72 0.0100
469 ABNORMAL LOSS OF WEIGHT 68 0.0100
470 UROSEPSIS 92 0.0100
471 ARRHYTHMIA 472 0.0100
472 VENTRICULAR SEPTAL DEFECT 57 0.0099
473 HEAD INJURY 311 0.0098
474 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 539 0.0098
475 CRYING 356 0.0098
476 THIRST 175 0.0098
477 ANOREXIA 126 0.0098
478 AMNESIA 635 0.0098
479 EXTRASYSTOLES 68 0.0097
480 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 692 0.0097
481 HEPATITIS CHOLESTATIC 58 0.0096
482 WRONG TECHNIQUE IN DRUG USAGE PROCESS 348 0.0096
483 ATRIAL SEPTAL DEFECT 80 0.0095
484 TRANSAMINASES INCREASED 212 0.0095
485 IRON DEFICIENCY ANAEMIA 88 0.0095
486 TOXIC SKIN ERUPTION 96 0.0095
487 GENERAL PHYSICAL HEALTH DETERIORATION 1100 0.0095
488 SLEEP DISORDER 671 0.0095
489 PANIC ATTACK 345 0.0095
490 HEPATOMEGALY 93 0.0095
491 EOSINOPHILIA 165 0.0094
492 ACTIVITIES OF DAILY LIVING IMPAIRED 186 0.0094
493 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 241 0.0094
494 ALANINE AMINOTRANSFERASE INCREASED 575 0.0094
495 LOSS OF CONSCIOUSNESS 1198 0.0093
496 HEPATITIS 239 0.0093
497 CARDIAC ARREST 766 0.0093
498 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 72 0.0093
499 CARDIOMEGALY 114 0.0093
500 CARDIOGENIC SHOCK 132 0.0092
501 ECONOMIC PROBLEM 139 0.0092
502 BODY TEMPERATURE INCREASED 187 0.0092
503 LYMPHOCYTE COUNT DECREASED 162 0.0092
504 HYPOPHAGIA 231 0.0090
505 BLOOD GLUCOSE FLUCTUATION 99 0.0090
506 INCORRECT PRODUCT STORAGE 118 0.0090
507 DEEP VEIN THROMBOSIS 582 0.0089
508 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 64 0.0089
509 HICCUPS 73 0.0089
510 HYPOTHYROIDISM 284 0.0089
511 EOSINOPHIL COUNT INCREASED 74 0.0089
512 PRODUCT PRESCRIBING ERROR 211 0.0088
513 SOMNAMBULISM 58 0.0088
514 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 60 0.0088
515 ATRIOVENTRICULAR BLOCK 68 0.0088
516 ASPARTATE AMINOTRANSFERASE INCREASED 467 0.0088
517 HEPATITIS ACUTE 57 0.0088
518 DISSOCIATION 67 0.0087
519 ACIDOSIS 66 0.0086
520 FALL 2874 0.0086
521 NERVOUS SYSTEM DISORDER 269 0.0086
522 BLOOD DISORDER 69 0.0086
523 DRUG SCREEN POSITIVE 68 0.0086
524 POOR QUALITY SLEEP 183 0.0085
525 ANAL INCONTINENCE 76 0.0084
526 ACUTE RESPIRATORY FAILURE 162 0.0084
527 CARDIAC FAILURE ACUTE 56 0.0084
528 MYOCARDIAL ISCHAEMIA 95 0.0083
529 THERAPY NON-RESPONDER 374 0.0083
530 RENAL FAILURE ACUTE 353 0.0083
531 UNDERDOSE 607 0.0083
532 EMBOLISM 69 0.0083
533 PRODUCT LABEL ISSUE 56 0.0082
534 MEDICAL DEVICE COMPLICATION 61 0.0082
535 INTENTIONAL PRODUCT MISUSE 722 0.0082
536 BLOOD ALKALINE PHOSPHATASE INCREASED 204 0.0082
537 FACIAL PARALYSIS 70 0.0082
538 PRODUCT PACKAGING ISSUE 78 0.0082
539 VENTRICULAR FIBRILLATION 91 0.0082
540 HEPATIC FUNCTION ABNORMAL 304 0.0081
541 INTESTINAL OBSTRUCTION 304 0.0081
542 MITRAL VALVE INCOMPETENCE 91 0.0080
543 HYDRONEPHROSIS 60 0.0080
544 NEUTROPENIA 1089 0.0080
545 RESPIRATORY RATE INCREASED 71 0.0080
546 DRUG DISPENSING ERROR 122 0.0080
547 HYPERHIDROSIS 1025 0.0079
548 LACTIC ACIDOSIS 257 0.0079
549 IMPAIRED WORK ABILITY 169 0.0079
550 SYNCOPE 790 0.0079
551 FACE OEDEMA 133 0.0079
552 STEVENS-JOHNSON SYNDROME 175 0.0079
553 DENTAL CARIES 87 0.0079
554 DRUG-INDUCED LIVER INJURY 245 0.0078
555 INJURY ASSOCIATED WITH DEVICE 159 0.0078
556 LIVER INJURY 191 0.0078
557 MUSCLE DISORDER 63 0.0078
558 ACUTE KIDNEY INJURY 1190 0.0078
559 TOXIC EPIDERMAL NECROLYSIS 118 0.0078
560 ATRIAL FLUTTER 62 0.0078
561 HAEMATOMA 201 0.0078
562 DRUG ERUPTION 137 0.0077
563 INSURANCE ISSUE 118 0.0077
564 MICTURITION URGENCY 88 0.0077
565 PARALYSIS 110 0.0077
566 SUBDURAL HAEMATOMA 110 0.0077
567 FRUSTRATION TOLERANCE DECREASED 62 0.0077
568 VENTRICULAR TACHYCARDIA 126 0.0076
569 ABASIA 188 0.0076
570 ACUTE RESPIRATORY DISTRESS SYNDROME 134 0.0076
571 BLOOD LACTATE DEHYDROGENASE INCREASED 120 0.0076
572 CEREBRAL DISORDER 56 0.0076
573 JOINT DISLOCATION 80 0.0076
574 ATELECTASIS 73 0.0075
575 BLOOD UREA INCREASED 126 0.0075
576 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 535 0.0075
577 CONSTIPATION 1635 0.0075
578 HYPERTENSION 1575 0.0074
579 DRUG WITHDRAWAL SYNDROME NEONATAL 110 0.0074
580 MUSCLE TIGHTNESS 120 0.0074
581 DYSSTASIA 215 0.0074
582 NOCTURIA 89 0.0073
583 MATERNAL DRUGS AFFECTING FOETUS 56 0.0073
584 ACCIDENTAL EXPOSURE TO PRODUCT 751 0.0073
585 HEPATIC ENZYME INCREASED 494 0.0072
586 NEUROTOXICITY 126 0.0072
587 BALANCE DISORDER 620 0.0072
588 MEMORY IMPAIRMENT 975 0.0071
589 DRUG EXPOSURE DURING PREGNANCY 241 0.0071
590 DISABILITY 140 0.0071
591 PANCYTOPENIA 395 0.0071
592 GAIT DISTURBANCE 1348 0.0070
593 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 367 0.0070
594 BLOOD PRESSURE DECREASED 466 0.0070
595 DEHYDRATION 933 0.0070
596 GASTROENTERITIS 102 0.0070
597 PRODUCT DOSE OMISSION 454 0.0069
598 RESPIRATORY DISORDER 208 0.0069
599 SWOLLEN TONGUE 217 0.0069
600 THROMBOCYTOPENIA 774 0.0069
601 NEUTROPHIL COUNT DECREASED 279 0.0068
602 PRODUCT PHYSICAL ISSUE 138 0.0068
603 CEREBRAL INFARCTION 167 0.0068
604 DYSURIA 251 0.0068
605 HYPOXIA 240 0.0068
606 DIZZINESS POSTURAL 66 0.0068
607 ARTERIOSCLEROSIS 64 0.0068
608 HEPATITIS C 82 0.0068
609 THERAPEUTIC RESPONSE DECREASED 411 0.0068
610 CARDIOVASCULAR DISORDER 172 0.0068
611 BLOOD GLUCOSE ABNORMAL 125 0.0068
612 RENAL IMPAIRMENT 567 0.0067
613 RENAL TUBULAR NECROSIS 66 0.0067
614 LACERATION 63 0.0067
615 URINE OUTPUT DECREASED 58 0.0066
616 SENSORY DISTURBANCE 105 0.0065
617 BLOOD CREATININE INCREASED 426 0.0065
618 THERAPY CHANGE 64 0.0065
619 BODY TEMPERATURE DECREASED 64 0.0065
620 HEART RATE INCREASED 644 0.0065
621 OEDEMA PERIPHERAL 792 0.0065
622 PALLOR 175 0.0064
623 NERVOUSNESS 335 0.0064
624 TREATMENT FAILURE 530 0.0064
625 MUSCLE ATROPHY 81 0.0064
626 HYPERKALAEMIA 224 0.0064
627 GENERALISED OEDEMA 79 0.0064
628 POLLAKIURIA 265 0.0063
629 RENAL FAILURE 843 0.0063
630 GASTRITIS 167 0.0063
631 INTENTIONAL DRUG MISUSE 132 0.0063
632 PULMONARY CONGESTION 83 0.0063
633 FRACTURE 119 0.0063
634 VISION BLURRED 861 0.0063
635 DISEASE RECURRENCE 298 0.0063
636 WOUND 175 0.0063
637 DRY MOUTH 506 0.0062
638 ERYTHEMA MULTIFORME 58 0.0062
639 PERICARDIAL EFFUSION 143 0.0062
640 BLOOD GLUCOSE INCREASED 1161 0.0062
641 RASH MACULO-PAPULAR 137 0.0062
642 PHARYNGITIS 76 0.0061
643 HYPERTHYROIDISM 88 0.0061
644 RESPIRATORY FAILURE 443 0.0061
645 SKIN LACERATION 66 0.0061
646 FOETAL EXPOSURE DURING PREGNANCY 493 0.0061
647 INTERVERTEBRAL DISC DEGENERATION 56 0.0060
648 CLOSTRIDIUM DIFFICILE COLITIS 64 0.0060
649 HYPERTENSIVE CRISIS 67 0.0060
650 GLYCOSYLATED HAEMOGLOBIN INCREASED 152 0.0060
651 POLYNEUROPATHY 72 0.0060
652 GASTROOESOPHAGEAL REFLUX DISEASE 483 0.0060
653 EJECTION FRACTION DECREASED 93 0.0060
654 BONE MARROW FAILURE 121 0.0059
655 DRUG INEFFECTIVE 7795 0.0059
656 HEMIPARESIS 100 0.0059
657 LIVER DISORDER 261 0.0059
658 FEELING ABNORMAL 1409 0.0059
659 MUSCULOSKELETAL CHEST PAIN 91 0.0059
660 JAUNDICE 157 0.0058
661 CONJUNCTIVITIS 107 0.0058
662 STAPHYLOCOCCAL INFECTION 189 0.0057
663 EXPOSURE DURING PREGNANCY 356 0.0057
664 PULMONARY OEDEMA 252 0.0056
665 HEART RATE IRREGULAR 127 0.0056
666 DISSEMINATED INTRAVASCULAR COAGULATION 79 0.0056
667 HAEMATEMESIS 142 0.0056
668 QUALITY OF LIFE DECREASED 75 0.0056
669 NO THERAPEUTIC RESPONSE 68 0.0056
670 PYREXIA 1926 0.0056
671 GASTRIC HAEMORRHAGE 64 0.0056
672 CHEST PAIN 1028 0.0055
673 URINARY TRACT INFECTION 940 0.0055
674 ABNORMAL DREAMS 151 0.0055
675 PERIPHERAL COLDNESS 75 0.0055
676 DEVICE BREAKAGE 221 0.0054
677 CELLULITIS 274 0.0054
678 WHITE BLOOD CELL COUNT DECREASED 588 0.0054
679 CARDIAC FAILURE 435 0.0054
680 ACUTE HEPATIC FAILURE 74 0.0054
681 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 259 0.0054
682 RENAL DISORDER 251 0.0054
683 PHOTOPHOBIA 101 0.0054
684 IMPAIRED GASTRIC EMPTYING 73 0.0053
685 GASTRIC ULCER 101 0.0053
686 DIPLOPIA 138 0.0053
687 PNEUMONIA 1717 0.0053
688 MUSCLE SPASTICITY 65 0.0053
689 RED BLOOD CELL COUNT DECREASED 151 0.0053
690 FEEDING DISORDER 107 0.0053
691 THYROID DISORDER 81 0.0052
692 PALPITATIONS 614 0.0052
693 SARS-COV-2 TEST POSITIVE 69 0.0052
694 DRUG INTOLERANCE 504 0.0052
695 OESOPHAGITIS 57 0.0052
696 VOMITING 2450 0.0052
697 PRODUCT QUALITY ISSUE 707 0.0052
698 OEDEMA 282 0.0052
699 WEIGHT DECREASED 1447 0.0052
700 OXYGEN SATURATION DECREASED 290 0.0052
701 PRODUCT AVAILABILITY ISSUE 117 0.0051
702 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 88 0.0051
703 ADVERSE REACTION 68 0.0051
704 CHOLECYSTITIS 61 0.0051
705 EYELID OEDEMA 59 0.0051
706 DRUG WITHDRAWAL SYNDROME 444 0.0051
707 EAR PAIN 98 0.0050
708 SPLENOMEGALY 59 0.0050
709 HAEMORRHOIDS 97 0.0050
710 BLINDNESS 202 0.0050
711 INTERNATIONAL NORMALISED RATIO INCREASED 141 0.0049
712 CONTRAINDICATED PRODUCT ADMINISTERED 149 0.0049
713 UNEVALUABLE EVENT 372 0.0049
714 NEUROPATHY PERIPHERAL 467 0.0049
715 RESPIRATORY TRACT CONGESTION 78 0.0049
716 VERTIGO 299 0.0049
717 CAESAREAN SECTION 57 0.0049
718 OSTEOPENIA 74 0.0049
719 SEPSIS 543 0.0049
720 PRODUCT PRESCRIBING ISSUE 106 0.0049
721 PLATELET COUNT INCREASED 63 0.0048
722 ROAD TRAFFIC ACCIDENT 202 0.0048
723 FEELING JITTERY 92 0.0048
724 ISCHAEMIC STROKE 86 0.0048
725 ANGINA PECTORIS 138 0.0048
726 TRANSIENT ISCHAEMIC ATTACK 162 0.0048
727 MUSCULAR WEAKNESS 545 0.0048
728 PNEUMOTHORAX 76 0.0048
729 TOOTHACHE 86 0.0047
730 MULTI-ORGAN FAILURE 82 0.0047
731 END STAGE RENAL DISEASE 86 0.0047
732 HIATUS HERNIA 61 0.0047
733 HEPATIC FAILURE 142 0.0047
734 HYPERCALCAEMIA 58 0.0047
735 BLOOD POTASSIUM DECREASED 141 0.0047
736 HEAD DISCOMFORT 83 0.0047
737 SCAR 80 0.0047
738 BRAIN FOG 73 0.0047
739 COLD SWEAT 82 0.0046
740 JOINT INJURY 99 0.0046
741 DECREASED APPETITE 1072 0.0046
742 PRODUCT SUBSTITUTION ISSUE 265 0.0046
743 IMPAIRED QUALITY OF LIFE 66 0.0046
744 RIB FRACTURE 94 0.0046
745 CHRONIC KIDNEY DISEASE 347 0.0046
746 HAEMATURIA 156 0.0046
747 RETCHING 97 0.0045
748 RENAL INJURY 135 0.0045
749 PLATELET COUNT DECREASED 482 0.0045
750 EYE DISORDER 148 0.0045
751 CARPAL TUNNEL SYNDROME 63 0.0045
752 MULTIPLE ORGAN DYSFUNCTION SYNDROME 127 0.0045
753 HAEMOGLOBIN DECREASED 460 0.0045
754 ASTHENIA 1677 0.0045
755 LYMPHOPENIA 63 0.0044
756 DIZZINESS 2221 0.0044
757 SEPTIC SHOCK 191 0.0044
758 PLEURAL EFFUSION 267 0.0044
759 HEART RATE DECREASED 154 0.0044
760 JOINT STIFFNESS 115 0.0044
761 BLOOD PRESSURE FLUCTUATION 104 0.0043
762 INCORRECT DOSE ADMINISTERED 989 0.0043
763 CORONARY ARTERY DISEASE 131 0.0043
764 DRUG EFFECT DECREASED 233 0.0043
765 CARDIAC DISORDER 403 0.0043
766 PHOTOSENSITIVITY REACTION 71 0.0043
767 TINNITUS 197 0.0043
768 MIDDLE INSOMNIA 80 0.0043
769 OSTEOPOROSIS 176 0.0043
770 ANGIOEDEMA 189 0.0043
771 SKIN LESION 117 0.0043
772 COAGULOPATHY 71 0.0043
773 ABDOMINAL PAIN 989 0.0042
774 EAR INFECTION 113 0.0042
775 INCORRECT ROUTE OF DRUG ADMINISTRATION 151 0.0042
776 PRESCRIBED UNDERDOSE 84 0.0042
777 GALLBLADDER DISORDER 75 0.0042
778 HYPOCALCAEMIA 79 0.0042
779 PERICARDITIS 70 0.0042
780 PRODUCT DOSE OMISSION ISSUE 1225 0.0042
781 HEPATIC CIRRHOSIS 78 0.0041
782 MUCOSAL INFLAMMATION 108 0.0041
783 MENORRHAGIA 81 0.0041
784 PREMATURE BABY 124 0.0041
785 ANAEMIA 784 0.0041
786 LUNG DISORDER 201 0.0041
787 VISUAL ACUITY REDUCED 136 0.0041
788 MELAENA 90 0.0041
789 ATRIAL FIBRILLATION 397 0.0041
790 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
791 MUSCLE SPASMS 741 0.0040
792 RECTAL HAEMORRHAGE 173 0.0040
793 PRODUCT COMPLAINT 102 0.0040
794 MOBILITY DECREASED 288 0.0040
795 NECK PAIN 224 0.0040
796 TOOTH LOSS 83 0.0040
797 ACUTE MYOCARDIAL INFARCTION 118 0.0040
798 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0040
799 FATIGUE 3098 0.0040
800 MALAISE 1737 0.0040
801 CEREBROVASCULAR ACCIDENT 667 0.0039
802 LUNG INFECTION 61 0.0039
803 PRESYNCOPE 95 0.0039
804 GLAUCOMA 75 0.0039
805 THERAPEUTIC RESPONSE SHORTENED 129 0.0039
806 CONTUSION 372 0.0039
807 WHEEZING 229 0.0039
808 BLOOD PRESSURE INCREASED 588 0.0038
809 ABDOMINAL DISTENSION 401 0.0038
810 GAIT INABILITY 128 0.0038
811 DYSPHONIA 224 0.0038
812 VISUAL IMPAIRMENT 473 0.0038
813 BACK DISORDER 62 0.0038
814 UPPER RESPIRATORY TRACT INFECTION 176 0.0038
815 SWELLING FACE 247 0.0038
816 VIRAL INFECTION 126 0.0038
817 BLOOD POTASSIUM INCREASED 61 0.0038
818 HYPOAESTHESIA 557 0.0037
819 PRODUCT DISPENSING ERROR 81 0.0037
820 CEREBRAL HAEMORRHAGE 133 0.0037
821 FOOT FRACTURE 70 0.0037
822 MYOCARDIAL INFARCTION 641 0.0037
823 BLOOD PRESSURE ABNORMAL 73 0.0037
824 ANKLE FRACTURE 56 0.0036
825 PULMONARY HYPERTENSION 75 0.0036
826 FEELING COLD 100 0.0036
827 BRONCHITIS 265 0.0036
828 DYSPNOEA 2023 0.0036
829 EPISTAXIS 264 0.0035
830 INTERVERTEBRAL DISC PROTRUSION 77 0.0035
831 MUSCULOSKELETAL PAIN 184 0.0035
832 SKIN DISORDER 117 0.0035
833 THERAPEUTIC PRODUCT EFFECT DECREASED 157 0.0035
834 IRRITABLE BOWEL SYNDROME 75 0.0035
835 DRUG EFFECT INCOMPLETE 127 0.0035
836 LIVER FUNCTION TEST INCREASED 75 0.0035
837 GASTROINTESTINAL DISORDER 312 0.0035
838 MENSTRUATION IRREGULAR 93 0.0035
839 DYSPEPSIA 337 0.0034
840 RESPIRATORY TRACT INFECTION 89 0.0034
841 NEURALGIA 83 0.0034
842 CHROMATURIA 76 0.0034
843 HEADACHE 2104 0.0034
844 LUNG NEOPLASM MALIGNANT 137 0.0033
845 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 674 0.0033
846 THERAPEUTIC RESPONSE UNEXPECTED 149 0.0033
847 RASH GENERALISED 86 0.0033
848 MATERNAL EXPOSURE DURING PREGNANCY 296 0.0033
849 ABORTION SPONTANEOUS 133 0.0033
850 NASAL CONGESTION 194 0.0033
851 LYMPHADENOPATHY 116 0.0033
852 INFECTION 474 0.0033
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 584 0.0032
854 NAUSEA 2531 0.0032
855 OSTEOARTHRITIS 135 0.0032
856 CARDIAC FAILURE CONGESTIVE 255 0.0032
857 GASTROINTESTINAL HAEMORRHAGE 265 0.0032
858 LIMB DISCOMFORT 98 0.0032
859 BLOOD URINE PRESENT 60 0.0032
860 CATARACT 188 0.0032
861 PROTEINURIA 60 0.0032
862 SKIN DISCOLOURATION 145 0.0032
863 BACK PAIN 733 0.0032
864 MUSCULOSKELETAL DISORDER 60 0.0031
865 HIP FRACTURE 100 0.0031
866 LIMB INJURY 84 0.0031
867 FLATULENCE 172 0.0030
868 CYSTITIS 96 0.0030
869 BURNING SENSATION 211 0.0030
870 KIDNEY INFECTION 59 0.0030
871 DERMATITIS 63 0.0030
872 ILL-DEFINED DISORDER 181 0.0030
873 SWELLING 275 0.0029
874 DEVICE ISSUE 262 0.0029
875 LIP SWELLING 97 0.0029
876 NEPHROLITHIASIS 133 0.0029
877 ABDOMINAL PAIN UPPER 594 0.0029
878 HAEMATOCHEZIA 158 0.0029
879 PARAESTHESIA 446 0.0028
880 DEAFNESS 74 0.0028
881 GASTRIC DISORDER 97 0.0028
882 DISCOMFORT 172 0.0028
883 EYE PAIN 159 0.0028
884 FLUID RETENTION 143 0.0028
885 DEATH 2418 0.0028
886 FIBROMYALGIA 68 0.0028
887 LOWER RESPIRATORY TRACT INFECTION 127 0.0028
888 INFLUENZA 306 0.0027
889 MYALGIA 465 0.0027
890 CHEST DISCOMFORT 280 0.0027
891 ASTHMA 309 0.0027
892 HAEMOPTYSIS 76 0.0027
893 CHILLS 319 0.0027
894 PAIN IN EXTREMITY 799 0.0027
895 COUGH 758 0.0027
896 THROAT TIGHTNESS 73 0.0027
897 HYPERSENSITIVITY 500 0.0027
898 ALOPECIA 527 0.0027
899 THROMBOSIS 215 0.0027
900 INTERSTITIAL LUNG DISEASE 129 0.0027
901 RHINORRHOEA 172 0.0027
902 IMPAIRED HEALING 87 0.0026
903 DIARRHOEA 1710 0.0026
904 FEMUR FRACTURE 82 0.0026
905 BLISTER 148 0.0026
906 PAIN 1614 0.0026
907 OROPHARYNGEAL PAIN 241 0.0026
908 INJECTION SITE MASS 96 0.0026
909 RASH ERYTHEMATOUS 124 0.0026
910 INFLAMMATION 133 0.0026
911 DRY EYE 128 0.0026
912 MIGRAINE 244 0.0026
913 EYE SWELLING 94 0.0025
914 LOCALISED INFECTION 61 0.0025
915 BLOOD GLUCOSE DECREASED 121 0.0025
916 FEELING HOT 154 0.0025
917 PAIN IN JAW 71 0.0025
918 ASCITES 71 0.0024
919 DRUG DEPENDENCE 388 0.0024
920 LABORATORY TEST ABNORMAL 71 0.0024
921 INTENTIONAL PRODUCT USE ISSUE 209 0.0024
922 RASH 1040 0.0024
923 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
924 SKIN ULCER 61 0.0024
925 INTENTIONAL DOSE OMISSION 67 0.0023
926 PHARMACEUTICAL PRODUCT COMPLAINT 61 0.0023
927 HAEMORRHAGE 242 0.0023
928 FUNGAL INFECTION 76 0.0023
929 OCULAR HYPERAEMIA 108 0.0023
930 ABDOMINAL DISCOMFORT 381 0.0023
931 ANAPHYLACTIC REACTION 124 0.0022
932 ACNE 170 0.0022
933 ECZEMA 117 0.0022
934 SURGERY 131 0.0022
935 BONE DENSITY DECREASED 70 0.0022
936 PRODUCTIVE COUGH 103 0.0022
937 ARTHROPATHY 119 0.0021
938 RASH PRURITIC 116 0.0021
939 DISEASE PROGRESSION 251 0.0021
940 MULTIPLE SCLEROSIS 101 0.0021
941 NEOPLASM PROGRESSION 73 0.0021
942 ILLNESS 216 0.0021
943 NASOPHARYNGITIS 382 0.0021
944 PERIPHERAL SWELLING 317 0.0021
945 NIGHT SWEATS 66 0.0020
946 ARTHRITIS 159 0.0020
947 BONE PAIN 115 0.0020
948 DYSPNOEA EXERTIONAL 72 0.0019
949 EXTRA DOSE ADMINISTERED 77 0.0019
950 URTICARIA 315 0.0019
951 COLITIS 71 0.0019
952 NO ADVERSE EVENT 336 0.0019
953 BREAST CANCER 172 0.0018
954 ERYTHEMA 372 0.0018
955 SINUSITIS 185 0.0018
956 ARTHRALGIA 747 0.0018
957 VAGINAL HAEMORRHAGE 76 0.0017
958 PRURITUS 671 0.0017
959 OSTEONECROSIS 57 0.0017
960 COVID-19 303 0.0017
961 RASH MACULAR 60 0.0017
962 SKIN EXFOLIATION 144 0.0017
963 INFLUENZA LIKE ILLNESS 137 0.0017
964 DYSGEUSIA 123 0.0017
965 EYE IRRITATION 95 0.0016
966 FEBRILE NEUTROPENIA 106 0.0016
967 MULTIPLE SCLEROSIS RELAPSE 108 0.0016
968 NEOPLASM MALIGNANT 103 0.0015
969 FLUSHING 156 0.0015
970 JOINT SWELLING 185 0.0015
971 HYPOACUSIS 63 0.0015
972 COLITIS ULCERATIVE 65 0.0015
973 INJECTION SITE HAEMORRHAGE 113 0.0014
974 HOT FLUSH 106 0.0014
975 PRODUCT STORAGE ERROR 123 0.0014
976 HERPES ZOSTER 77 0.0013
977 STOMATITIS 76 0.0013
978 PSORIASIS 161 0.0012
979 THERAPY INTERRUPTED 88 0.0012
980 DEPENDENCE 67 0.0012
981 INJECTION SITE PAIN 373 0.0012
982 INJECTION SITE SWELLING 90 0.0012
983 INJECTION SITE REACTION 79 0.0011
984 DRY SKIN 148 0.0011
985 SKIN BURNING SENSATION 77 0.0011
986 INFUSION RELATED REACTION 56 0.0008
987 INJECTION SITE ERYTHEMA 99 0.0008
988 MALIGNANT NEOPLASM PROGRESSION 81 0.0008
989 RHEUMATOID ARTHRITIS 83 0.0007